Premier Inc. Adds Roche HIV-1 Test to Existing Contract
Complete the form below to unlock access to ALL audio articles.
Premier Inc. gave its 1,700 hospital members access in August to the Roche COBAS® Ampliprep/COBAS® TaqMan® HIV-1 assay -- the only real-time PCR test for HIV offered to its members.
Premier added the new HIV-1 monitoring test, COBAS® TaqMan® 48 Analyzer and COBAS® TaqMan® Analyzer to its existing three-year molecular contract so that customers could combine the COBAS® Ampliprep, which was included in the existing molecular contract, with the COBAS® TaqMan® and the docking station to experience full automation.
"Adding the Roche HIV-1 monitoring test to Premier's menu is consistent with our mission to quickly roll out the highest level of innovation to our customers," said John Biggers, Group Vice President of Sourcing at Premier.
"Premier also added COBAS® Taqman® 48 Analyzer, COBAS® Taqman® Analyzer and Roche's unique docking station so that customers could take advantage of the test's full automation while offering to their patients the most advanced HIV-1 monitoring assay based on 11 years of experience in HIV monitoring."
Roche introduced the fully automated COBAS® Ampliprep/COBAS® TaqMan® in response to customers' needs for a system that could allow their molecular laboratory technicians to load samples and walk away, not returning until the sample results are ready.
"Molecular technicians are in high demand," said Susan Zienowicz, Vice President for Molecular Diagnostics of Roche Diagnostics. "In creating the COBAS® Ampliprep/COBAS® TaqMan® HIV-1 assay, we provide labs with another strategy to help them leverage their employees' time and get more done in the lab."
